2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine

Catalog No. :
ACOWGU854
CAS No. :
2396570-49-1
Molecular Formula :
C30H21N9
Molecular Weight :
507.56

IUPAC Name:2,4,6-tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine

2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$73.00Login to see priceIn stockInquiry
250mg95%$122.00Login to see priceIn stockInquiry
1g95%$327.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine
IUPAC Name2,4,6-tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine
Molecular FormulaC30H21N9
Molecular Weight507.56
SMILESC1(C2=CC=C(C3=CNN=C3)C=C2)=NC(C4=CC=C(C5=CNN=C5)C=C4)=NC(C6=CC=C(C7=CNN=C7)C=C6)=N1
InChI KeyMLHVKCKZHMZXEW-UHFFFAOYSA-N
Synonym2,4,6-tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine;tris[4-(1H-pyrazol-4-yl)phenyl]-1,3,5-triazine;1,3,5-Triazine, 2,4,6-tris[4-(1H-pyrazol-4-yl)phenyl]-
CAS No.2396570-49-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACOWGU854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYUSO179 route compound structure diagram
    ACYUSO179269410-08-4 In Stock
  4. Then
  5. ACOWGU854 route product structure diagram
    ACOWGU8542396570-49-1 In Stock
Inquiry

2. ACOWGU854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRCWX846 route compound structure diagram
    ACRCWX846763120-58-7 In Stock
  4. Then
  5. ACOWGU854 route product structure diagram
    ACOWGU8542396570-49-1 In Stock
Inquiry

Comments (0)